-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Rhythm Pharmaceuticals, Raises Price Target to $155

Benzinga·08/05/2026 17:06:46
语音播报
RBC Capital analyst Lisa Walter maintains Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Outperform and raises the price target from $141 to $155.